Manufacturer record
Pratima Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Pratima Pharmaceuticals (Maharashtra) were declared Not of Standard Quality between May 2025 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Pratima Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Fluconazole 150mg Tablets IP (PRATIFLU 150 Tablets | PPTS-2801Mfg 2024-08 · Exp 2027-07 | The content of Fluconazole in the sample is less (i.e 31.96% of the stated amount) (I.P. Limits:- Not less than 90% and not more than 110% of the stated Amount)Other | V.P. Khedkar, Pune-Zone 2State lab | May 2025 |
| Azithromycin Tablets IP 500mg (Ronnin 500 Tablets) | PPTC082Mfg 2023-11 · Exp 2026-10 | 1. The sample does gives identification for the presence of Azithromycin 2. Additional identification:-The sample gives identification for the presence of Paracetamol.3. Found Content of Paracetamol in the sample is 147.24mg/TabIdentification | S.K, Jadhav, Pune-Zone 3 , FDA Lab, M.S. Chhatrapati Sambhajinagar . Maharashtra StateState lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.